|
|
||||||||||
Clinical Assistant Professor, Department of Pharmacy Practice; Affiliate Faculty, Center for Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL
Research Fellow, Center for Pharmacoeconomic Research
Clinical Assistant Professor, Department of Pharmacy Practice and Section of Cardiology, University of Illinois at Chicago
Clinical Assistant Professor, Department of Pharmacy Practice, University of Illinois at Chicago
Vice President, Pharmacy Services, Mercy Resource Management, Inc., Naperville, IL; Clinical Assistant Professor, Department of Pharmacy Practice, University of Illinois at Chicago
Coordinator of Clinical Pharmacy Programs, Mercy Resource Management, Inc., Naperville, IL; Clinical Assistant Professor, Department of Pharmacy Practice, University of Illinois at Chicago
Director, Center for Pharmacoeconomic Research, University of Illinois at Chicago; Associate Professor, Department of Pharmacy Practice, University of Illinois at Chicago
Reprints: Glen T Schumock PharmD MBA FCCP, Center for Pharmacoeconomic Research, University of Illinois at Chicago, 833 S. Wood St. (M/C 886), Chicago, IL 60612-7230, fax 312/996-0379, schumock{at}uic.edu
OBJECTIVE: To describe the development of guidelines for the treatment of acute decompensated heart failure (ADHF) in the emergency department/observation unit (ED-OU) setting for hospitals that are part of a group purchasing organization (GPO).
DATA SOURCES: A MEDLINE search (1966March 2003) using the following search terms: cardiotonic agents; diuretic; dobutamine; heart failure, congestive; milrinone; natriuretic peptide, brain; nesiritide; nitroglycerin; vasodilator agents, was conducted.
STUDY SELECTION AND DATA EXTRACTION: Relevant articles in the English language were identified. All randomized studies and meta-analyses for each category of drugs were included.
DATA SYNTHESIS: A group consensus method was used to develop guidelines. An expert panel reviewed and revised the guidelines. The final guidelines were approved June 1, 2003, and are described here. They are organized based upon a patient's symptomatology at the time the diagnosis of ADHF is made. Patients with evidence of volume overload require intravenous diuretics and/or intravenous vasodilators to alleviate the symptoms of ADHF. Patients with signs and symptoms of low cardiac output require inotropic support to manage their ADHF. A timeline for diagnosis, treatment, reassessment, and disposition is provided and encourages an early, aggressive approach to treating patients with ADHF.
CONCLUSIONS: Hospitalization for ADHF is common and costly. Consensus guidelines for the treatment of ADHF did not previously exist, resulting in inconsistent and inefficient treatment. Consequently, hospitals struggling with the treatment of ADHF may find these guidelines and the process by which they were developed useful.
Key Words: emergency department, guidelines, heart failure, observation unit
Published Online, February 24, 2004. www.theannals.com, DOI 10.1345/aph.1D481
THIS ARTICLE IS APPROVED FOR CONTINUING EDUCATION CREDIT
ACPE UNIVERSAL PROGRAM NUMBER: 407-000-04-015-H01
This article has been cited by other articles:
![]() |
J. L. Schuberth, T. A. Elasy, J. Butler, R. Greevy, T. Speroff, R. S. Dittus, and C. L. Roumie Effect of Short Call Admission on Length of Stay and Quality of Care for Acute Decompensated Heart Failure Circulation, May 20, 2008; 117(20): 2637 - 2644. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J DiDomenico, A. Perez, H. M Schumann, D. R Fontana, G. T Kondos, and G. T Schumock Impact of Treatment Guidelines on Clinical and Economic Outcomes of Acute Decompensated Heart Failure Ann. Pharmacother., March 1, 2008; 42(3): 327 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vats, R. J DiDomenico, J. E Wojtynek, J. C Theobald, and G. T Schumock Hospital Policies for Treatment of Acute Decompensated Heart Failure Ann. Pharmacother., April 1, 2007; 41(4): 562 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Arora Nesiritide: trials and tribulations. Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2006; 11(3): 165 - 169. [Abstract] [PDF] |
||||
![]() |
L. Groban and J. Butterworth Perioperative management of chronic heart failure. Anesth. Analg., September 1, 2006; 103(3): 557 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fontana Nesiritide: The Latest Drug for Treating Heart Failure Crit. Care Nurse, February 1, 2006; 26(1): 39 - 47. [Full Text] [PDF] |
||||
![]() |
Part 7.4: Monitoring and Medications Circulation, December 13, 2005; 112(24_suppl): IV-78 - IV-83. [Full Text] [PDF] |
||||
![]() |
G. C. Fonarow, C. W. Yancy, J. T. Heywood, and for the ADHERE Scientific Advisory Committee, Stud Adherence to Heart Failure Quality-of-Care Indicators in US Hospitals: Analysis of the ADHERE Registry Arch Intern Med, July 11, 2005; 165(13): 1469 - 1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schumock Correction: guidelines for acute decompensated heart failure treatment Ann. Pharmacother., June 1, 2004; 38(6): 1090 - 1090. [Full Text] [PDF] |
||||